Alprazolam Tablets — Class II drug recall D-0186-2020
Terminated recall by Mylan Pharmaceuticals Inc., reported 2019-11-13, distributed nationwide. Presence of Foreign Substance
| Recall number | D-0186-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Mylan Pharmaceuticals Inc., Morgantown, WV, United States |
| Recall initiated | 2019-10-23 |
| Classified | 2019-11-05 |
| Reported by FDA | 2019-11-13 |
| Terminated | 2020-12-10 |
| Distributed | Nationwide (US) |
| Quantity | 5,760 bottles |
| NDC | 00378-4003-05 |
| Lot numbers | 8082708 |
| Expiration dates | 2020-09-20 |
Product
Alprazolam Tablets, USP 0.5 mg, 500-count bottles, Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 Made in Australia, NDC 0378-4003-05
Reason for recall
Presence of Foreign Substance
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0186-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.